title: Evolution of blood pressure and cholesterol in stage 1 hypertension: role of autonomic nervous system activity.
abstract: OBJECTIVE
  Controversy remains concerning the pathogenetic mechanisms for the relationship between sympathetic activity, hypertension and lipid abnormalities. We tested the hypothesis that a condition characterized by sympathetic predominance may affect the evolution of blood pressure and lipids in the early stage of hypertension.
  
  
  METHODS
  We prospectively studied 163 young stage 1 hypertensive individuals and 28 normotensive control individuals. The hypertensive subjects were divided by cluster analysis into two groups according to low frequency and high frequency components of heart rate variability. Large artery and small artery compliance was assessed at the end of the follow-up.
  
  
  RESULTS
  Fifty-nine subjects showed reduced total power and signs of sympathetic predominance in the resting condition, on standing and during mental stress (group 1). At baseline, they had similar blood pressure and metabolic data to the rest of the group (n = 104, group 2) and a greater white-coat effect (P = 0.03). During a 6-year follow-up, 23.7% of group 1 subjects versus 9.6% of group 2 subjects developed sustained hypertension requiring antihypertensive treatment (P = 0.02). In group 1 subjects, there was also a greater increase in total cholesterol (P = 0.01) than in group 2. In addition, at the end of follow-up group 1 subjects had impaired large artery compliance (P < 0.001 versus group 2).
  
  
  CONCLUSIONS
  These data indicate that a condition characterized by sympathetic predominance may favour the development of sustained hypertension and hypercholesterolemia early in life, and lead to increased susceptibility to vascular complications. They further indicate that the increased white-coat effect is not an innocent phenomenon.
authors.affiliation: Dipartimento di Medicina Clinica e Sperimentale, University of Padova, Padua, Italy. palatini@ux1.unipd.it
authors.forename: Paolo
authors.initials: P
authors.lastname: Palatini
authors.forename: Daniele
authors.initials: D
authors.lastname: Longo
authors.forename: Vania
authors.initials: V
authors.lastname: Zaetta
authors.forename: Davor
authors.initials: D
authors.lastname: Perkovic
authors.forename: Raffaella
authors.initials: R
authors.lastname: Garbelotto
authors.forename: Achille C
authors.initials: AC
authors.lastname: Pessina
mesh_terms: D000328:Adult; D000704:Analysis of Variance; D001145:Arrhythmias, Cardiac / Q000209:etiology / Q000503:physiopathology*; D015992:Body Mass Index; D002784:Cholesterol / Q000097:blood; D016000:Cluster Analysis; D004548:Elasticity; D005260:Female; D006339:Heart Rate / Q000502:physiology*; D006801:Humans; D006937:Hypercholesterolemia / Q000503:physiopathology*; D006973:Hypertension / Q000503:physiopathology*; D008297:Male; D008365:Manometry / Q000295:instrumentation / Q000379:methods; D011446:Prospective Studies; D011673:Pulsatile Flow; D017534:Radial Artery; D018709:Statistics, Nonparametric; D013564:Sympathetic Nervous System / Q000503:physiopathology*
chemical_list: D002784:Cholesterol